Michael W N Deininger

34PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|Dec 27, 2024
Novel treatment strategies for chronic myeloid leukemia.

Nataly Cruz-Rodriguez, Michael W Deininger

|Aug 07, 2024
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.

Fieke W Hoff, William G Blum, Ying Huang

Pageof 6

Frequent Collaborators

9 joint publications

Jorge E Cortes

8 joint publications

Daniel J DeAngelo

6 joint publications

Michael Mauro

6 joint publications

Brian J Druker